Journals / Literatür Eczacılık Bilimleri Dergisi / 2020 / Cilt: 9 - Sayı: 1

Toxicological Evaluation of Probiotics

Probiyotiklerin Toksikolojik Açıdan Değerlendirilmesi

Pages
42–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, toxicological safety and risk analysis of probiotics identified as living microorganisms, which are very popular all over the world and given sufficient amounts, are evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The number of bacteria in the human body is much higher than their own cell count.
📊
Key Findings & Data:This bacterium formed by bacteria in the body is defined as microbiota.
💡
Conclusion & Impact:In this review, toxicological safety and risk analysis of probiotics identified as living microorganisms, which are very popular all over the world and given sufficient amounts, are evaluated.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The number of bacteria in the human body is much higher than their own cell count. This bacterium formed by bacteria in the body is defined as microbiota. Depending on their general field of use, probiotics are defined as living microorganisms that can either qualitatively or quantitatively alter intestinal microflora, support the immune system and trigger beneficial effects. These bacteria have health effects as well as the drugs used and the additional probiotics taken have an effect on the microbiota. Probiotics are known to have beneficial effects, but there is still insufficient study on the safe use of these preparations. This requires an uncontrolled questioning of the safety of such widely used probiotics. In this review, toxicological safety and risk analysis of probiotics identified as living microorganisms, which are very popular all over the world and given sufficient amounts, are evaluated.

Özet

İnsan vücudunda kendi hücrelerinden çok daha fazla sayıda bakteri yaşamaktadır. Bakterilerin vücutta oluşturduğu bu bakteri topluluğu mikrobiyota olarak ifade edilmektedir. Genel kullanım alanlarına bağlı olarak probiyotikler, kalitatif veya kantitatif olarak bağırsak mikroflorasını değiştirebilen, bağışıklık sistemini destekleyerek yararlı etkilerini tetikleyen, canlılar tarafından tüketilen canlı mikroorganizmalar şeklinde tanımlanmaktadır. Probiyotiklerin yararlı etkileri olduğu bilinmekle beraber, bu preparatların güvenli kullanımı üzerine yeterince çalışma bulunmamaktadır. Bu durum, kontrolsüz bir şekilde bu kadar yaygın olarak kullanılan probiyotiklerin güvenliliklerinin de sorgulanmasını gerektirmektedir. Bu derlemede, tüm dünyada çok popüler olan ve yeterli miktarda verildiğinde hastaya yarar sağlayan canlı mikroorganizmalar olarak tanımlanan probiyotiklerin kullanımının toksikolojik açıdan güvenirliliği ve risk analizi değerlendirilmiştir.

🔖

Cite This Article

ÖZMEN, E., SABUNCUOĞLU, S. (2020). Toxicological Evaluation of Probiotics. Literatür Eczacılık Bilimleri Dergisi, Cilt: 9 - Sayı: 1, 42–49. https://ajindex.com/articles/274573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019
  2. 76(3):473-93. [Crossref] [PubMed] 2. Anand S, Mande SS. Diet, microbiota and gutlung connection. Front Microbiol. 2018
  3. [Crossref] [PubMed] [PMC] 3. Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health. 2014
  4. 11(5):4745-67. [Crossref] [PubMed] [PMC] 4. Anukam KC. Probiotic toxicity, any evidence? J Pharmacol Toxicol. 2007
  5. 2(7):590-8. [Crossref] 5. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989
  6. 66(5):365-78. [Crossref] [PubMed] 6. Fuller R. Reasons for the apparent variation in the probiotic response. Biologia. 2006
  7. 61(6):751-4. [Crossref] 7. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, et al. Demonstration of safety of probiotics--a review. Int J Food Microbiol. 1998
  8. 44(1-2):93-106. [Crossref] [PubMed] 8. Riquelme AJ, Calvo MA, Guzmán AM, Depix MS, García P, Pérez C, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol. 2003
  9. 36(1):41- 3. [Crossref] [PubMed] 9. Sotoudegan F, Daniali M, Hassani S, Nikfar S, Abdollahi M. Reappraisal of probiotics’ safety in human. Food Chem Toxicol. 2019
  10. [Crossref] [PubMed] 10. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 1991
  11. 70(6):443-59. [Crossref] [PubMed] 11. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000
  12. 130(2S Suppl):396S-402S. [Crossref] [PubMed] 12. Feng P, Ye Z, Kakade A, Virk AK, Li X, Liu P. A review on gut remediation of selected environmental contaminants: possible roles of probiotics and gut microbiota. Nutrients. 2018
  13. 11(1). pii: E22. [Crossref] [PubMed] [PMC] 13. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011
  14. 474(7351):327-36. [Crossref] [PubMed] [PMC] 14. Quigley EMM. Prebiotics and probiotics in digestive health. Clin Gastroenterol Hepatol. 2019
  15. 17(2):333-44. [Crossref] [PubMed] 15. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019
  16. 25(5):716-29. [Crossref] [PubMed] 16. Lee ES, Song EJ, Nam YD, Lee SY. Probiotics in human health and disease: from nutribiotics to pharmabiotics. J Microbiol. 2018
  17. 56(11):773-82. [Crossref] [PubMed] 17. Sanders ME. Probiotic